Kodiak sciences inc. (KOD)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
Cash flows from operating activities
Net loss

-63,773

-47,365

-46,411

-44,483

-40,507

-41,443

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

528

538

528

506

498

490

0

0

0

Non-cash interest expense and amortization of debt discount and issuance cost

-

-

-

-

-

5,482

0

0

0

Change in fair value of redeemable convertible preferred stock warrant liability

-

-

-

-

-

2,700

0

0

0

Change in fair value of derivative instrument

-

-

-

-

-

1,988

0

0

0

Stock-based compensation

11,035

6,110

5,290

4,317

3,730

2,665

0

0

0

Amortization (accretion) of premium (discount) on marketable securities

348

241

0

0

0

-

-

-

-

Amortization of operating lease right-of-use asset

0

-

-

-

0

-

-

-

-

Amortization of issuance costs

0

-

-

-

-

-

-

-

-

Changes in assets and liabilities:
Prepaid expenses and other current assets

284

168

-290

1,882

1,922

1,995

0

0

0

Operating lease right-of-use asset

-

-

-

-

-

-

0

0

0

Other assets

6,113

4,511

0

0

0

-

-

-

-

Accounts payable

2,862

1,569

51

864

-346

-2,323

0

0

0

Accrued and other current liabilities

6,274

4,932

2,886

1,521

1,283

-2,105

0

0

0

Operating lease liability

-442

-383

0

0

0

-

-

-

-

Other liabilities

-

-

-

-

-

31

0

0

0

Net cash used in operating activities

-49,871

-39,146

-36,193

-33,481

-24,979

-29,031

0

0

0

Cash flows from investing activities
Purchase of property and equipment

610

437

306

166

85

78

0

0

0

Purchase of available-for-sale securities

-

-

-

-

-

-

0

0

0

Purchase of marketable securities

0

-

-

-

0

-

-

-

-

Maturities of marketable securities

0

-

-

-

-

-

-

-

-

Net cash used in investing activities

-180,323

-136,998

-24,240

-23,735

-24,453

-581

0

0

0

Cash flows from financing activities
Proceeds from issuance of common stock, net of offering costs

-

-

-

-

-

83,755

0

0

0

Proceeds from issuance of common stock upon options exercise

0

-

-

-

0

-

-

-

-

Proceeds from sale of future royalties, net of issuance costs

0

-

-

-

-

-

-

-

-

Proceeds from issuance of convertible notes (includes $9,560 and $8,000 from related parties for the years ended December 31, 2018 and 2017, respectively)

-

-

-

-

-

33,000

0

0

0

Deferred offering costs

-

-

-

-

-

-

0

0

0

Debt issuance cost

-

-

-

-

-

140

0

0

0

Principal payments of capital lease

26

48

68

88

108

108

0

0

0

Principal payments of tenant improvement allowance payable

0

-

-

-

0

-

-

-

-

Principal payments of tenant improvement allowance payable

-

-

-

-

-

-

-

0

0

Net cash provided by financing activities

399,428

299,687

85,876

84,542

83,841

116,471

0

0

0

Net increase (decrease) in cash, cash equivalents and restricted cash

169,234

123,543

25,443

27,326

34,409

86,859

0

0

0

Supplemental disclosures of non-cash investing and financing information:
Operating lease right-of-use asset obtained in exchange for operating lease liability

-

-

-

-

0

-

-

-

-

Unpaid offering costs

-

-

-

-

-

205

0

0

0

Purchase of property and equipment under accounts payable

-

-

-

0

0

-

-

-

-

Derivative instrument related to convertible notes

-

-

-

-

-

6,603

0

0

0